By Sam Boughedda
Investing.com -- Eli Lilly (NYSE: LLY ) stock rose over 3% in early Thursday trading after the company reported first-quarter earnings, beating earnings and revenue expectations.
The company reported adjusted earnings per share of $2.62 on revenue of $7.81 billion, beating estimates of $2.28 on revenue of $7.32 billion.
Lilly's revenue in Q1 increased 15%. Excluding revenue from COVID-19 antibodies and Alimta, revenue grew 10%.
The company's revenue from COVID-19 antibodies was $1.47 billion compared with $810.1 million in Q1 2021. On Wednesday, GlaxoSmithKline (NYSE: GSK ) beat earnings and revenue estimates, thanks to a boost in sales from its COVID-19 antibody.
"Lilly delivered another quarter of volume-driven revenue growth led by key products and anticipates 2022 to be an exciting year with several potential approvals and new pipeline events," said David Ricks, Lilly's chair and CEO.
"With the depth of our pipeline, and growth of our medicines in the market, we are well-positioned to help address health challenges in areas of significant unmet medical need, such as obesity, Alzheimer's disease, and cancer," he added.
Looking ahead, the company sees adjusted EPS for 2022 between $8.15 to $8.30.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.